Webinar
30
Jan
2023
2023
17
00
CET
CET
Interstitial Lung Disease (ILD): a rare but severe side-effect
This session is part of the SPCC Adverse Events Management and Interstitial Lung Disease (ILD) Detection Project. Following the Task Force - held in 2022 - the fourth phase of the project will focus on the results emerged from the discussion on the new strategies to tackle adverse events on Interstitial Lung Disease Cancer.
Speakers
![](https://attachment.oncocorner.net/48/2024011911470197.jpg)
Discussant
Rugo Hope
Winterhof Family Professor of Breast Cancer Director, Breast Oncology and Clinical Trials Education Medical Director, Cancer Infusion Services, San Francisco, USA
![](https://attachment.oncocorner.net/48/2022092611001994.jpeg)
Expert
Addeo Alfredo
Oncology Division, University Hospital Geneva, Geneve, Switzerland
![](https://attachment.oncocorner.net/48/2022111412461528.jpg)
Expert
Bergeron Anne
Pneumology Dept., Hôpitaux Universitaires Genève, Geneva, Switzerland
Expert
Senan Suresh
Amsterdam University Medical Centers, VUmc location, Amsterdam, The Netherlands
This material is part of Educational
Project:
2022 - Adverse Events Management and Interstitial Lung Disease (ILD) Detection Project